| CASE REPORT |
|
| Year : 2021 | Volume
: 23
| Issue : 2 | Page : 88-91 |
|
|
Strongyloides hyperinfection syndrome in a patient with COVID 19
Beena Philomina Jose, Shivapriya P Charu, Vishnu Kaniyarakkal
Department of Microbiology, Government Medical College, Kozhikode, Kerala, India
Correspondence Address:
Dr. Beena Philomina Jose
Department of Microbiology, Government Medical College, Kozhikode - 673 008, Kerala
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/jacm.jacm_62_21
|
|
|
The severe acute respiratory syndrome coronavirus 2 (SARS CoV 2) which started the corona virus disease 2019 (COVID 19) outbreak is an RNA virus commonly spread via respiratory droplets. The infection may remain asymptomatic or present with mild upper respiratory symptoms or take a severe form with pneumonia and severe acute respiratory distress syndrome (ARDS) that requires assisted ventilation and presents complications with negative outcome. Rate of co-infections and super-infections in hospitalised COVID 19 patients even though low when compared to other respiratory infections, may cause severe disease with worse outcome when present. Here we present a case of strongyloides hyperinfection syndrome complicating SARS CoV-2 infection possibly brought on by the use of immune altering therapy for COVID 19.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
Next article
